The coordinated document set
Clinical protocol
Scope, roles, assessment, product workflow, treatment documentation, aftercare, follow-up, and escalation.
Authority and orders
State-appropriate prescribing, ordering, supervision, or delegation documentation.
Patient forms
Intake, procedure-specific consent, pre-care, aftercare, photography choices, and urgent contact instructions.
Safety records
Emergency checklist, supply checks, adverse-event report, referral pathway, training, drills, and version control.
Core protocol sections
Provider roles and patient assessment
Identify who evaluates, prescribes or orders, treats, supervises, and handles complications. Organize relevant history, allergies, medications, prior procedures, goals, anatomy, contraindications, and deferral criteria.
Product and source
Name each FDA-approved filler, its labeled indications, authorized supplier, storage, lot tracking, expiration, and product-specific instructions. Avoid treating fillers as interchangeable.
Preparation and treatment workflow
Define identity and site verification, photography, skin preparation, aseptic technique, supplies, mapping, documentation, patient monitoring, and stop criteria.
Aftercare and follow-up
Coordinate expected effects, restrictions, concerning symptoms, contact routes, planned reassessment, late complications, and continuity of care.
FDA identifies unintended injection into a blood vessel as the most serious filler risk because it can cause tissue necrosis, blindness, or stroke. The clinic’s approved emergency pathway must be immediately usable-not buried in a general policy.
Treatment-record checklist
- Assessment and treatment indication
- Consent and photography status
- Exact product and formulation
- Lot number and expiration
- Supplier and traceability
- Treatment areas and mapping
- Technique and amount by area
- Patient response and endpoint
- Aftercare and return precautions
- Follow-up and communications
Emergency readiness belongs beside the protocol
The clinic’s qualified leadership should define recognition, immediate actions, clinical leadership contact, emergency services activation, ophthalmic or specialty escalation where indicated, transfer, documentation, product reporting, follow-up, and quality review. Supplies must match the approved response plan and staff must be trained within their roles.
Accessible instructions
Use a concise emergency checklist supported by the full approved policy.
Verified supplies
Assign inventory, expiration, storage, and availability checks.
Defined contacts
Keep current internal leadership, emergency, transfer, and specialty contact pathways.
Training evidence
Document education, competency, drills, and corrective actions.
Review before implementation
Compare the protocol with current product labeling, state scope and supervision rules, provider training, the consent, treatment record, infection-prevention program, emergency plan, insurance requirements, and the clinic’s real capabilities. Final approval remains with qualified clinical leadership.
Selected authoritative resources
Frequently asked questions
Should hyaluronidase be included?
If the clinic uses hyaluronic-acid filler, qualified leadership should determine its emergency supplies, authorization, protocol, dosing framework, training, documentation, and state-specific requirements.
Can one protocol cover every filler?
A shared framework is possible, but product indications, warnings, storage, traceability, and instructions must remain product-specific.
Who can inject filler?
That depends on state law, professional license, supervision, delegation, training, and the clinic’s circumstances. The protocol cannot expand scope of practice.
Build a clinic-specific filler package.
Coordinate the protocol, applicable orders, consent, intake, treatment record, aftercare, checklists, and safety materials around your clinic.
Build My Protocol